substantiation for rational antibacterial therapy of respiratory bacterial diseases in children
Clicks: 199
ID: 223316
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
199 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #52 of 94 articles by views in scientific electronic archives
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
This article discusses the current state of the problem of antibiotic therapy for bacterial respiratory infections in children. The use of third generation cephalosporin — cefpodoxime proxetil (Cefodox) in respiratory diseases is scientifically substantiated. The experience of foreign and domestic experts, as well as our own experience of using cefpodoxime proxetil in the treatment of respiratory bacterial infections in children, is provided.
| Reference Key |
lezhenko2015zdorovesubstantiation
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;H.O. Lezhenko;O.Ye. Pashkova |
| Journal | scientific electronic archives |
| Year | 2015 |
| DOI |
10.22141/2224-0551.1.60.2015.74945
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.